Acción ELYM ELIEM THERAPEUTICS, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Eliem Therapeutics, Inc.

Acciones

ELYM

US28658R1068

Mercado cerrado - Nasdaq
Otros sitios de cotización
 22:00:00 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
3,98 USD +17,40 % Gráfico intradía de Eliem Therapeutics, Inc. +3,38 % +47,41 %
11/04 Actualización del sector: Los valores del sector sanitario bajan a última hora de la tarde MT
11/04 Principales ganancias del mediodía MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Kaskela Law LLC Announces Investigation of Eliem Therapeutics, Inc. (ELYM) and Encourages Investors to Contact the Firm
Sector Update: Health Care Stocks Softer Late Afternoon
Top Midday Gainers
Sector Update: Health Care Stocks Decline Thursday Afternoon
Eliem Therapeutics to Acquire Tenet Medicines; Launching Private Placement -- Eliem Shares Surge
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders
Top Premarket Gainers
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Eliem Therapeutics, Inc. and Tenet Medicines, Inc. Announces Management and Organization Changes
Eliem Therapeutics, Inc. entered into a definitive acquisition agreement to acquire Tenet Medicines, Inc.
Eliem Therapeutics, Inc. announced that it expects to receive $119.955003 million in funding from RA Capital Management, L.P., Deep Track Capital, LP
Eliem Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Harpoon Therapeutics Appoints Chief Legal Officer, Chief People Officer
Eliem Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Eliem Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Eliem Therapeutics Drops Kv7 Program, Explores Strategic Alternatives
Eliem Therapeutics Plans to Explore Strategic Alternatives
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
Eliem Therapeutics : Corporate Presentation – May 2023
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción ELYM
  4. Noticias Eliem Therapeutics, Inc.
  5. Otros idiomas